Back to results

CompletedPhase 3

Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression

NCT00285766

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Mohammed Bari, M.D.

Chula Vista, California, United States

+14 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2002-08
Enrollment: 300 participants
Sponsor: Somerset Pharmaceuticals
Purpose: treatment

Locations (15)

Mohammed Bari, M.D.Chula Vista, California, United States
Charles Meredith, M.D.San Diego, California, United States
Daniel Zimbroff, M.D.Upland, California, United States
Kathleen Toups, M.D.Walnut Creek, California, United States
Abbey Strauss, M.D.Boynton Beach, Florida, United States
Barry Baumel, M.D.Miami Beach, Florida, United States
Margarita Nunez, M.D.St. Petersburg, Florida, United States
Mildred Farmer, M.D.St. Petersburg, Florida, United States
Larry Eisner, M.D.Tamarack, Florida, United States
Andrew Cutler, M.D.Winter Park, Florida, United States
Robert Riesenberg, M.D.Atlanta, Georgia, United States
James Hartford, M.D.Florence, Kentucky, United States
Mitchel Kling, M.D.Baltimore, Maryland, United States
Louise Beckett, M.D.Oklahoma City, Oklahoma, United States
Penny Barnhart, M.D.Wichita Falls, Texas, United States

Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression — TrialFind